Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are able to follow basic instructions and can sit comfortably while wearing some sensor leads attached to your body.
- You are experiencing symptoms of stress, anxiety, or sleep problems, and you score at or above a certain level on at least one of the following self-reported questionnaires: the Insomnia Severity Index (score of 8 or more), the Perceived Stress Scale (score of 14 or more), or the Generalized Anxiety Disorder 7-item scale (score of 5 or more).
Who may not be able to join:
- You are unable or unwilling to give your informed consent to take part in the study.
- You are not able to travel to the study location or cannot sit comfortably in a chair for up to 1.5 hours.
- You have severe hearing loss, as the study involves using earbuds.
- You weigh more than 285 pounds, due to the weight limit of the chair used in the study.
- You are currently taking part in another active research study that involves an intervention.
- You have used HIRREM, Brainwave Optimization, Cereset, or a wearable version of these technologies (B2 or B2v2) within the last 3 years.
- You have previously received electroconvulsive therapy (ECT), which is a type of brain stimulation treatment (confirm with trial site).
- You have used certain brain stimulation or feedback therapies — including transcranial magnetic stimulation (TMS), transcranial direct current stimulation (TDCS), alpha stimulation, neurofeedback, biofeedback, or deep brain stimulation (DBS) — within the past month.
- You have a known seizure disorder (epilepsy).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Charles Tegeler, MD, Wake Forest University Health Sciences
Phone: 336-716-9447
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Heart Rate Variability; Change in Baroreflex Sensitivity; Change in Blood Pressure Variability
Can't join this trial?
Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.